Stay updated on Anetumab Ravtansine Multi-indication Clinical Trial

Sign up to get notified when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anetumab Ravtansine Multi-indication Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Locations section updated with a revised global list of study sites across multiple regions (e.g., U.S. states, Australia, Canada, Europe, and others). This corresponds to Revision: v3.3.3.
    Difference
    2%
    Check dated 2025-12-17T21:49:28.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-26T13:57:15.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Removed the generic government funding status notice about data recency and operations. The study details on the page remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-19T08:42:43.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Core study details, eligibility criteria, outcomes, and locations appear unchanged; the observed differences seem limited to cosmetic or layout changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-28T05:19:45.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Significant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 reference removed.
    Difference
    3%
    Check dated 2025-10-06T16:09:23.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-29T10:08:44.000Z thumbnail image

Stay in the know with updates to Anetumab Ravtansine Multi-indication Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.